New cancer clinical trial: Papaverine Hydrochloride and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Published on: January 31, 2019 at 12:00PM
Condition:   Lung Non-Small Cell Carcinoma
Interventions:   Procedure: Blood Oxygen Level Dependent Imaging;   Drug: Papaverine Hydrochloride;   Radiation: Stereotactic Body Radiation Therapy
Sponsors:   Ohio State University Comprehensive Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting
http://bit.ly/2TpDmBL